Remicade, Humira, Simponi, and Cimzia manage autoimmune conditions like inflammatory bowel disease and psoriasis by inhibiting TNF-α and TNFR1 interaction, thereby moderating inflammation and modulating immune responses. Here, TNF is linked to psoriasis.